Tagliaferri MA, Schwartzberg LS, Chen MM, Camacho LH, Kaplan EH, Arena FP, Bienvenu BJ, North SE, Li D. A Phase 2b trial of Coix seed extract injection for advanced pancreatic cancer. ASCO.org and JCO.org, 2013. e15023
Schwartzberg LS, Scott D, and Li D. Integrating A Non-Traditional (Parenteral) Chinese Medicine Into Community Based Oncology. Multinational Association of Supportive Care in Cancer Annual Conference in Boston, MA, June 28-30, 2012
Woo JH, Li D, Wilsbach K, Orita H, Coulter J, Tully E, Kwon TK, Xu S, Gabrielson E. Coix Seed Extract, Commonly Used Treatment for Cancer in China, Inhibits NFkB and Protein Kinase C Signaling. Cancer BiolTher. 2007 Dec; 6(12):2005-11. Epub Oct 13, 2007
Deng SG, Wen SB, and Chen AL. Clinical observation of Kanglaite Injection Combined with Gemzar and Carboplatin in the Treatment of Mid and Late Stage NSCLC. Zhejiang Practical Medicine 2006; 11:234-6
Liang Z, Wang W, Gao J, Liu T, Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, P.R. China. Preliminary study of effect of Kanglaite Injection combined with Gemzar on transplanted human pancreatic carcinoma in nude mice; Chinese Journal of Cancer Prevention and Treatment; 2006-03
Wheeler RH, Busby L, Samlowski W, Gerard R, and Farling H. Phase I Study of Kanglaite Injection (KLT), a Botanical Product based on Chinese Medicine. Proceedings of ASCO 2003; Abstr 990
Busby LT, Jing J, Samlowski WE, McGregor JR, Farling H, and Wheeler RH. Phase I and Pharmacokinetic Study of Kanglaite Injection (KLT), a Botanical Product based on Traditional Chinese Medicine. Proceedings of ASCO 2002; Abstr 2192
Cui CX, Li JL, Hao XZ, Chu DT, and Wang JW. A Clinical Observation of Kanglaite Injection in Combination with PVM Scheme in Treating Intermediate and Late Stage NSCLC. Qi Lu Journal of Oncology. 1997;4: 310-11; report of Phase III study